Pseudorabies Virus Vaccine Market Size, Share, and COVID-19 Impact Analysis by Product Type, Application, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Mar 2024
Report ID:HC-1003
Base Year:2023
Report Format:PDF, Excel
Report Pages:183
Region:Global

Table of Content

  1. Global Pseudorabies Virus Vaccine Market Introduction and Market Overview

1.1. Objective of the Study

1.2. Global Pseudorabies Virus Vaccine Market Scope and Market Estimation

1.2.1. Global Pseudorabies Virus Vaccine Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)

1.2.2. Global Pseudorabies Virus Vaccine Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030

1.3. Market Segmentation

1.3.1. Product Type of Global Pseudorabies Virus Vaccine Market

1.3.2. Application of Global Pseudorabies Virus Vaccine Market

1.3.3. Region of Global Pseudorabies Virus Vaccine Market

  1. Global Pseudorabies Virus Vaccine Market - Executive Summary

2.1. Key Findings

2.1.1. Top Impacting Factors

2.1.2. Top Investment Pockets

2.1.3. Market Attractiveness Analysis

2.2. Key Companies Introduction

  1. Market Factor Analysis

3.1. Global Pseudorabies Virus Vaccine Market Industry Development Trends under COVID-19 Outbreak

3.1.1. Global COVID-19 Status Overview

3.1.2. Influence of COVID-19 Outbreak on Global Pseudorabies Virus Vaccine Market Industry Development

3.2. Market Dynamics (Growth Influencers)

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.2.4. Impact Analysis of Drivers and Restraints

3.3. Ecosystem/ Value Chain Analysis

3.4. Porter’s Five Forces Analysis

3.5. SWOT Analysis

3.6. PEST Analysis

3.7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)

3.7.1. By Product Type

3.7.2. By Application

  1. Global Pseudorabies Virus Vaccine Market: Estimates & Historic Trend Analysis (2017-2020)
  2. Global Pseudorabies Virus Vaccine Market Estimates & Forecast Trend Analysis, by Product Type

5.1. Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, by Product Type, 2022 & 2030

5.1.1. Key Market Trends, Growth Factors, and Opportunities

5.2. Pseudorabies Virus Vaccine Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2017 to 2030

5.2.1. Key Market Trends, Growth Factors, and Opportunities

5.3. Inactivated Vaccine

5.4. Naturally Deficient Attenuated Vaccine

5.5. Genetic Engineering Vaccine

  1. Global Pseudorabies Virus Vaccine Market Estimates & Forecast Trend Analysis, by Application

6.1. Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, by Application, 2022 & 2030

6.1.1. Key Market Trends, Growth Factors, and Opportunities

6.2. Pseudorabies Virus Vaccine Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2017 to 2030

6.2.1. Key Market Trends, Growth Factors, and Opportunities

6.3. Government Tender

6.4. Market Sales

  1. Global Pseudorabies Virus Vaccine Market Analysis and Forecast, by Region

7.1. Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030

7.1.1. Key Market Trends, Growth Factors, and Opportunities

7.2. Pseudorabies Virus Vaccine Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030

7.2.1. Key Market Trends, Growth Factors, and Opportunities

7.2.2. North America

7.2.3. Europe

7.2.4. Asia Pacific

7.2.5. Middle East and Africa

7.2.6. South America

  1. North America Pseudorabies Virus Vaccine Market: Estimates & Forecast Trend Analysis

8.1. North America Market Assessments & Key Findings

8.2. North America Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, 2022 & 2030

8.3. North America Pseudorabies Virus Vaccine Market Size Estimates and Forecast (US$ Million) (2017 to 2030)

8.3.1. By Product Type

8.3.2. By Application

8.3.3. By Country

8.3.3.1. U.S.

8.3.3.2. Canada

8.3.3.3. Mexico

  1. Europe Pseudorabies Virus Vaccine Market: Estimates & Forecast Trend Analysis

9.1. Europe Market Assessments & Key Findings

9.2. Europe Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, 2022 & 2030

9.3. Europe Pseudorabies Virus Vaccine Market Size Estimates and Forecast (US$ Million) (2017 to 2030)

9.3.1. By Product Type

9.3.2. By Application

9.3.3. By Country

9.3.3.1. Germany

9.3.3.2. U.K.

9.3.3.3. France

9.3.3.4. Italy

9.3.3.5. Spain

9.3.3.6. Russia

9.3.3.7. Rest of Europe

  1. Asia Pacific Pseudorabies Virus Vaccine Market: Estimates & Forecast Trend Analysis

10.1. Asia Pacific Market Assessments & Key Findings

10.2. Asia Pacific Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, 2022 & 2030

10.3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)

10.3.1. By Product Type

10.3.2. By Application

10.3.3. By Country

10.3.3.1. China

10.3.3.2. Japan

10.3.3.3. India

10.3.3.4. Australia

10.3.3.5. South Korea

10.3.3.6. Rest of Asia Pacific

  1. Middle East & Africa Pseudorabies Virus Vaccine Market: Estimates & Forecast Trend Analysis

11.1. Middle East & Africa Market Assessments & Key Findings

11.2. Middle East & Africa Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, 2022 & 2030

11.3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)

11.3.1. By Product Type

11.3.2.By Application

11.3.3. By Country

11.3.3.1. U.A.E.

11.3.3.2. Saudi Arabia

11.3.3.3. Egypt

11.3.3.4. South Africa

11.3.3.5. Rest of Middle East & Africa

  1. South America Pseudorabies Virus Vaccine Market: Estimates & Forecast Trend Analysis

12.1. South America Market Assessments & Key Findings

12.2. South America Pseudorabies Virus Vaccine Market Share (%) Estimates and Forecasts, 2022 & 2030

12.3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)

12.3.1.By Product Type

12.3.2. By Application

12.3.3. By Country

12.3.3.1. Brazil

12.3.3.2. Argentina

12.3.3.3. Colombia

12.3.3.4. Rest of South America

  1. Manufacturing Cost Structure Analysis

13.1. Raw Material and Suppliers

13.2. Manufacturing Cost Structure Analysis of Pseudorabies Virus Vaccine

13.3. Manufacturing Process Analysis of Pseudorabies Virus Vaccine

13.4. Industry Chain Structure of Pseudorabies Virus Vaccine

  1. Marketing, Distributors and Customer

14.1. Sales Channel

14.1.1. Direct Channels

14.1.2. Indirect Channels

14.2. Pseudorabies Virus Vaccine Distributors

14.3. Pseudorabies Virus Vaccine Customer

  1. Competition Landscape

15.1. Key Manufacturers Pseudorabies Virus Vaccine Producing Area Distribution, Sales Area, Product Type

15.2. Key Manufacturers Pseudorabies Virus Vaccine Product Location Distribution

15.3. Market Competition Matrix, by Leading Players

15.3.1.Competition Landscape Analysis

15.3.2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

15.4. List of Emerging, Prominent and Leading Players

15.5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.

  1. Company Profiles

16.1. Merial Limited

16.1.1. Company Information

16.1.2. Pseudorabies Virus Vaccine Product Offered

16.1.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.1.4. Main Business Overview

16.1.5. Latest Developments

16.2. Boehringer Ingelheim Animal Health (USA) Co., Ltd.

16.2.1. Company Information

16.2.2. Pseudorabies Virus Vaccine Product Offered

16.2.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.2.4. Main Business Overview

16.2.5. Latest Developments

16.3. Zoetis

16.3.1. Company Information

16.3.2. Pseudorabies Virus Vaccine Product Offered

16.3.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.3.4. Main Business Overview

16.3.5. Latest Developments

16.4. Hipra

16.4.1. Company Information

16.4.2. Pseudorabies Virus Vaccine Product Offered

16.4.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.4.4. Main Business Overview

16.4.5. Latest Developments

16.5. Anhui Divinity Biological Products

16.5.1. Company Information

16.5.2. Pseudorabies Virus Vaccine Product Offered

16.5.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.5.4. Main Business Overview

16.5.5. Latest Developments

16.6. Wuhan Keqian Biological Co., Ltd.

16.6.1. Company Information

16.6.2. Pseudorabies Virus Vaccine Product Offered

16.6.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.6.4. Main Business Overview

16.6.5. Latest Developments

16.7. China Biotechnology Co., Ltd.

16.7.1. Company Information

16.7.2. Pseudorabies Virus Vaccine Product Offered

16.7.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.7.4. Main Business Overview

16.7.5. Latest Developments

16.8. CHINA ANIMAL HUSBANDRY INDUSTRY

16.8.1. Company Information

16.8.2. Pseudorabies Virus Vaccine Product Offered

16.8.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.8.4. Main Business Overview

16.8.5. Latest Developments

16.9. Sichuan Huashen

16.9.1. Company Information

16.9.2. Pseudorabies Virus Vaccine Product Offered

16.9.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.9.4. Main Business Overview

16.9.5. Latest Developments

16.10. Haley

16.10.1. Company Information

16.10.2. Pseudorabies Virus Vaccine Product Offered

16.10.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.10.4. Main Business Overview

16.10.5. Latest Developments

16.11. Tianbang

16.11.1. Company Information

16.11.2. Pseudorabies Virus Vaccine Product Offered

16.11.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.11.4. Main Business Overview

16.11.5. Latest Developments

16.12. Dabei Nong

16.12.1. Company Information

16.12.2. Pseudorabies Virus Vaccine Product Offered

16.12.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.12.4. Main Business Overview

16.12.5. Latest Developments

16.13. Harvey

16.13.1. Company Information

16.13.2. Pseudorabies Virus Vaccine Product Offered

16.13.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.13.4. Main Business Overview

16.13.5. Latest Developments

16.14. Preh Bio

16.14.1. Company Information

16.14.2. Pseudorabies Virus Vaccine Product Offered

16.14.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.14.4. Main Business Overview

16.14.5. Latest Developments

16.15. Jiangsu Nannong High-Tech Co.

16.15.1. Company Information

16.15.2. Pseudorabies Virus Vaccine Product Offered

16.15.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.15.4. Main Business Overview

16.15.5. Latest Developments

16.16. Guangxi Liyuan Biological Co., Ltd.

16.16.1. Company Information

16.16.2. Pseudorabies Virus Vaccine Product Offered

16.16.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.16.4. Main Business Overview

16.16.5. Latest Developments

16.17. Jilin Zhengye Bioengineering Group

16.17.1. Company Information

16.17.2. Pseudorabies Virus Vaccine Product Offered

16.17.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.17.4. Main Business Overview

16.17.5. Latest Developments

16.18. Jilin Heyuan Biological Engineering Co., Ltd.

16.18.1. Company Information

16.18.2. Pseudorabies Virus Vaccine Product Offered

16.18.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.18.4. Main Business Overview

16.18.5. Latest Developments

16.19. Huapai Biological Engineering Group Co., Ltd.

16.19.1. Company Information

16.19.2. Pseudorabies Virus Vaccine Product Offered

16.19.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.19.4. Main Business Overview

16.19.5. Latest Developments

16.20. Beijing Xinde Weite Technology Co., Ltd.

16.20.1. Company Information

16.20.2. Pseudorabies Virus Vaccine Product Offered

16.20.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.20.4. Main Business Overview

16.20.5. Latest Developments

16.21. Beijing Veterinary Biopharmaceutical Factory

16.21.1. Company Information

16.21.2. Pseudorabies Virus Vaccine Product Offered

16.21.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.21.4. Main Business Overview

16.21.5. Latest Developments

16.22. Qilu Animal Health Products Co., Ltd

16.22.1. Company Information

16.22.2. Pseudorabies Virus Vaccine Product Offered

16.22.3. Pseudorabies Virus Vaccine Sales, Revenue, Price, and Gross Margin (2018-2022)

16.22.4. Main Business Overview

16.22.5. Latest Developments

  1. Assumptions and Research Methodology
  2. Conclusions and Recommendations

18.1. Analysis and Suggestions on New Project Investment

18.2. Research Findings and Conclusion

List of Tables

Table1 Global Pseudorabies Virus Vaccine Market Historic Analysis (US$ Mn), 2017-2021

Table2 Global Pseudorabies Virus Vaccine Market Forecast Opportunity Analysis (US$ Mn), 2022-2030

Table3 Global Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table4 Global Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table5 Global Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table6 Global Pseudorabies Virus Vaccine Market Analysis by Region, 2017-2030

Table7 North America Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table8 North America Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table9 North America Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table10 North America Pseudorabies Virus Vaccine Market Analysis by Country, 2017-2030

Table11 South America Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table12 South America Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table13 South America Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table14 South America Pseudorabies Virus Vaccine Market Analysis by Country, 2017-2030

Table15 Europe Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table16 Europe Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table17 Europe Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table18 Europe Pseudorabies Virus Vaccine Market Analysis by Country, 2017-2030

Table19 Asia Pacific Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table20 Asia Pacific Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table21 Asia Pacific Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table22 Asia Pacific Pseudorabies Virus Vaccine Market Analysis by Country, 2017-2030

Table23 MEA Pseudorabies Virus Vaccine Market Absolute $ Opportunity

Table24 MEA Pseudorabies Virus Vaccine Market Analysis by Product Type, 2017-2030

Table25 MEA Pseudorabies Virus Vaccine Market Analysis by Application, 2017-2030

Table26 MEA Pseudorabies Virus Vaccine Market Analysis by Country, 2017-2030

List of Figures

Figure1 Global Pseudorabies Virus Vaccine Market Historic Y-o-Y Analysis (%), 2017-2021

Figure2 Global Pseudorabies Virus Vaccine Market Forecast Y-o-Y Analysis (%), 2022-2030

Figure3 Global Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure4 Global Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure5 Global Pseudorabies Virus Vaccine Market Share Analysis by Region, 2021 and 2030

Figure6 North America Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure7 North America Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure8 North America Pseudorabies Virus Vaccine Market Share Analysis by Country, 2021 and 2030

Figure9 South America Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure10 South America Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure11 South America Pseudorabies Virus Vaccine Market Share Analysis by Country, 2021 and 2030

Figure12 Europe Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure13 Europe Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure14 Europe Pseudorabies Virus Vaccine Market Share Analysis by Country, 2021 and 2030

Figure15 Asia Pacific Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure16 Asia Pacific Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure17 Asia Pacific Pseudorabies Virus Vaccine Market Share Analysis by Country, 2021 and 2030

Figure18 MEA Pseudorabies Virus Vaccine Market Share Analysis by Product Type, 2021 and 2030

Figure19 MEA Pseudorabies Virus Vaccine Market Share Analysis by Application, 2021 and 2030

Figure20 MEA Pseudorabies Virus Vaccine Market Share Analysis by Country, 2021 and 2030

market statsville report image

Want to Review Complete Market Research Report

$3150  $2450 save 23%
$4950  $3850 save 25%
$7680  $5100 save 30%

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Budget constrains? Get in touch with us for special pricing
Request Discount

Phone: +1 (888) 615 4898

Email: sales@regionalresearchreports.com

Chat with Us: Click here to start